Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
Chendong Yang,1,* Aihua Hou,1,2,* Chunfeng Yu,1 Lingling Dai,1 Wen Wang,1 Kangle Zhang,1 Hongmin Shao,1 Jinghua Ma,1 Wenjuan Xu2 1Yantai Hospital of Traditional Chinese Medicine, 2Binzhou Medical University, Yantai, China *These authors contributed equally to this work Background: Multidrug resis...
Main Authors: | Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/kanglaite-reverses-multidrug-resistance-of-hcc-by-inducing-apoptosis-a-peer-reviewed-article-OTT |
Similar Items
-
Kanglaite for Treating Advanced Non-small-cell Lung Cancer: A Systematic Review
by: Lina ZHU, et al.
Published: (2009-03-01) -
Efficacy of Paclitaxel Combined with Kanglaite Injection in Treatment of Bone Metastases of Lung Cancer
by: Liming CAO, et al.
Published: (2019-07-01) -
Effect of Kanglaite combined with chemotherapy on myelosuppression, immune function and tumor markers levels in patients with breast cancer
by: Qi Pan, et al.
Published: (2017-09-01) -
Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation
by: Xicheng Wang, et al.
Published: (2020-03-01) -
Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis
by: Fanming Kong, et al.
Published: (2021-09-01)